411 results on '"Roberts, Harold R."'
Search Results
2. Clinical Role of Recombinant Factor Vlla in Bleeding Disorders
3. Clinical Trials of Recombinant Factor VIII
4. Haemophilia and Haemostasis: A Case-based Approach to Management
5. Recombinant factor VIIa: how safeis the stuff?
6. Less Common Congenital Disorders of Hemostasis
7. Contributors
8. Cutaneous wound healing is impaired in hemophilia B
9. The biology of haemostasis and thrombosis
10. Contributors
11. Less Common Congenital Disorders of Hemostasis
12. Editorial
13. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia
14. A Cell-Based Model of Thrombin Generation
15. Thrombin Biology in the 21st Century
16. Novel Therapeutic Agents in the Management of Hemorrhage and Thrombosis
17. The use of recombinant factor VIIa in the treatment of bleeding disorders
18. High dose factor VIIa improves clot structure and stability in a model of haemophilia B
19. Safety profile of recombinant factor VIIa
20. Monitoring coagulation and the clinical effects of recombinant factor VIIa
21. Identification of the Molecular Defect in Factor IXChapel Hill: Substitution of Histidine for Arginine at Position 145
22. OSCAR RATNOFF: HIS CONTRIBUTIONS TO THE GOLDEN ERA OF COAGULATION RESEARCH
23. The dysfibrinogenaemias
24. High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system
25. Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk
26. The Factor VII-Platelet Interplay: Effectiveness of Recombinant Factor VIIa in the Treatment of Bleeding in Severe Thrombocytopathia
27. Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces
28. Overview of anticoagulant drugs for the future
29. Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo
30. Reply: Hypercoagulable States
31. Platelet activity of high-dose factor VIIa is independent of tissue factor
32. Replacing the First Epidermal Growth Factor-like Domain of Factor IX with That of Factor VII Enhances Activity In Vitro and in Canine Hemophilia B
33. Hypercoagulability in Venous and Arterial Thrombosis
34. New perspectives on the coagulation cascade
35. The endothelial cell binding determinant of human factor IX residue in the gamma-carboxyglutamic acid domain
36. 5 - Less Common Congenital Disorders of Hemostasis
37. Hemophilias
38. Contributors
39. Clinical Role of Recombinant Factor Vlla in Bleeding Disorders
40. The Treatment of Factor VIII Inhibitors � A General Overview
41. Dental Treatment of Patients with Hemorrhagic Disorders
42. Factor IX Deficiency or Hemophilia B: Clinical Manifestations and Management
43. Perivascular tissue factor is down-regulated following cutaneous wounding: implications for bleeding in hemophilia
44. Hemophilia and Hemostasis
45. Liver Biopsy in Hemophilia A
46. Intravascular Coagulation with Use of Human Prothrombin Complex Concentrates
47. Thrombogenic Materials in Prothrombin Complex Concentrates
48. Proposed Symbols for Factor VIII and von Willebrand Factor
49. CLINICAL USE OF A NEW GLYCINE-PRECIPITATED ANTIHEMOPHILIC FRACTION
50. ACQUIRED INHIBITORS OF PLASMA FACTOR IX A STUDY OF THEIR INDUCTION, PROPERTIES AND NEUTRALIZATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.